Health Ministry Halts Use of Specific Similac Hospital Formula Batch
Translated & summarized from Panet by baba
Israel's Ministry of Health has ordered a precautionary halt to the use of a specific batch of Similac infant formula distributed only to hospitals following a single complaint. The manufacturer is providing an alternative batch.
The story in 5 lines · by baba
- Ministry of Health halts specific Similac hospital formula batch.
- Decision follows a single complaint about batch 89203N201.
- Formula is hospital-exclusive, not sold in retail.
- No other complaints or health issues reported.
- Manufacturer Abbott is supplying replacement batches.
Israel's Ministry of Health announced on Tuesday a precautionary halt to the use of a specific batch of "Similac" formula intended exclusively for hospitals. The decision followed a single complaint received on Monday evening concerning batch number 89203N201, which is printed on the bottom of the container. This particular batch is distributed only to hospitals and is not available for retail sale, pending the completion of an investigation.
Currently, the ministry stated, there is only one reported complaint, and no other reports have been received regarding any health issues linked to the product. Abbott, the manufacturer, is working to supply hospitals with an alternative batch.
These instructions apply solely to the specified batch, and no restrictions have been placed on other Similac batches. The ministry emphasized that the measure is a precautionary step while the examination is underway.
Mentioned
